Contrast Dose
Management
Contrast Dose
Management
Contrast Dose Management Can Help You Optimize Radiology Workflows
From the point of care through to post procedure, Radimetrics® – the Contrast Dose Management Platform offered by Bayer in Radiology – helps you automate manual processes, directly impacting key areas of the complete radiology workflow.
Put Contrast Dose Management to work.
Get the benefits of automated documentation accuracy and workflow efficiency
- Eliminate repetitive, manual documentation, and dictation for more efficient radiology workflows
- Automate contrast documentation for greater documentation accuracy and consistency
- Auto-populate contrast injection records directly into RIS, PACS, and Speech Reporting (SR)
- Mitigate billing rework and down-coding by automating documentation
Take advantage of accessible insights
- Close information gaps, and gain the insights you need to make better decisions
- Evaluate outcomes, and link them to technical factors, technologists, and equipment
.
Experience streamlined best-practice compliance
- Standardize contrast documentation processes
- Respond to increased interest in tracking contrast agent information
- Accreditation bodies and professional organizations (including The Joint Commission and ACR) now agree that contrast information should be captured in medical records
Leverage measurable gains in quality
- Automatically capture quality metrics in a central location
- Identify variations in performance, patterns, and trends
- Prepare for future quality initiatives
Deliver enhanced care
- Increase time for patients by spending less time on paperwork and repetitive documentation
.
Gain cumulative insights on MR patients
- Monitor cumulative MR contrast dose over time
- Monitor MR contrast utilization in the enterprise
Obtain personalized dose insights for CT patients
- Set alerts for CT contrast volume thresholds over 24-hour periods
- Monitor contrast usage to reduce CT contrast agent spend through more precise utilization
- Monitor patient’s time-based contrast dose thresholds
Any individuals depicted on this web page are actors and not actual health care providers or patients.
Patient Information listed on the Graphical User Interfaces are fictitious examples only and do not contain any actual patient data.
MRI images throughout this website are actual patient cases but all personal identifiers have been removed or otherwise anonymized. No personally identifiable information is shown.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2020-2023 Bayer
BAYER, the Bayer Cross, MEDRAD Stellant, MEDRAD MRXperion, MEDRAD Stellant FLEX, MEDRAD XDS, MEDRAD Veris, MEDRAD Stellant P3T, MEDRAD Spectris Solaris, MEDRAD Spectris, MEDRAD Mark 7 Arterion, MEDRAD Mark V ProVis, MEDRAD Intego, MEDRAD Avanta, MEDRAD Twist & Go, MEDRAD VFlow, Certegra P3T, MEDRAD FluiDots, MEDRAD Vistron, MEDRAD Envision, MEDRAD Certo, MEDRAD, Stellant, MRXperion, Stellant FLEX, Veris, Spectris Solaris, Spectris, Mark 7 Arterion, Mark V ProVis, Avanta, Envision, Twist & Go, VFlow, Radimetrics, Certegra, P3T, Seamlessly Smart, DirectCARE, PartnerCARE, VirtualCare, SelectCARE, and TechCARE are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.
Bayer HealthCare LLC 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981
Last update: February 2023